Fecal calprotectin is significantly linked to azathioprine metabolite concentrations in Crohn's disease

ColonoscopyInflammatory Bowel Disease

Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn's disease

BMC Gastroenterol.

Somwaru AS, Khanijow V, Katabathina VS

doi: 10.1186/s12876-019-1125-7.

Inflammatory Bowel Disease

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease

BMC Gastroenterol.

Strömbeck A, Lasson A, Strid H, Sundin J, Stotzer PO, Simrén M, Magnusson MK, Öhman L

doi: 10.1186/s12876-020-01281-4.

Inflammatory Bowel Disease

Fecal biomarkers in inflammatory bowel diseases: calprotectin versus lipocalin-2 - a comparative study

J Crohns Colitis.

Zollner A, Schmiderer A, Reider SJ, Oberhuber G, Pfister A, Texler B, Watschinger C, Koch R, Effenberger M, Raine T, Tilg H, Moschen AR

doi: 10.1093/ecco-jcc/jjaa124.

Colonoscopy

Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence

World J Gastroenterol.

Baillet P, Cadiot G, Goutte M, Goutorbe F, Brixi H, Hoeffel C, Allimant C, Reymond M, Obritin-Guilhen H, Magnin B, Bommelaer G, Pereira B, Hordonneau C, Buisson A

doi: 10.3748/wjg.v24.i5.641.

Inflammatory Bowel Disease

Cannabis for the treatment of Crohn's disease

Cochrane Database Syst Rev.

Kafil TS, Nguyen TM, MacDonald JK, Chande N

doi: 10.1002/14651858.

Inflammatory Bowel Disease

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease

BMC Gastroenterol.

E Penna FGC, Rosa RM, da Cunha PFS, de Souza SCS, de Abreu Ferrari ML

doi: 10.1186/s12876-020-1183-x.

Inflammatory Bowel Disease

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Lancet Gastroenterol Hepatol.

Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group

doi: 10.1016/S2468-1253(19)30012-3.

Inflammatory Bowel Disease

Riboflavin supplementation in patients with Crohn's disease (RISE-UP study)

J Crohns Colitis.

von Martels JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, Sadaghian Sadabad M, Vich Vila A, Gacesa R, Gabriëls RY, Steinert RE, Jansen BH, Bulthuis MLC, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, de Vos P, van Goor H, Faber KN, Harmsen HJM, Dijkstra G

doi: 10.1093/ecco-jcc/jjz208.

RECOMMENDED

Esophagus Diseases

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors and Disease Course

J Crohns Colitis.

Greuter T, Piller A, Fournier N, Safroneeva E, Straumann A, Biedermann L, Godat S, Nydegger A, Scharl M, Rogler G, Vavricka SR, Schoepfer AM; Swiss IBD Cohort Study Group

doi: 10.1093/ecco-jcc/jjy121.

Related content

Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn's disease

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease

Fecal biomarkers in inflammatory bowel diseases: calprotectin versus lipocalin-2 - a comparative study

Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence

Cannabis for the treatment of Crohn's disease

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Riboflavin supplementation in patients with Crohn's disease (RISE-UP study)

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors and Disease Course